Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout

Cohort 1 is completed, and Cohort 2 is 80% recruited Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 5, 2023 - Addex...

Related Keywords

Geneva ,Genè ,Switzerland ,United States ,American ,Swiss ,Mike Sinclair ,Tim Dyer ,Swiss Exchange ,Janssen Pharmaceutical Companies Of Johnson ,Janssen Pharmaceuticals Inc ,Nasdaq ,Hoc Announcement Pursuant ,Janssen Pharmaceuticals ,Janssen Pharmaceutical Companies ,Interim Review Committee ,Addex Therapeutics ,American Depositary Shares ,Executive Officer ,Halsin Partners ,Swiss Stock Exchange Adxn ,